Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2019 Apr 24;91(1):48–57. doi: 10.1111/cen.13986

Table 1:

Clinical and Demographic Characteristics

Variable Mean (SD) or n (%)
Age at V2 (years), mean (SD) 48.6 (2.7)
BMI at V2, kg/m2, mean (SD) 28.0 (7.2)
Race/ethnicity, n (%)
  Black 386 (24.4)
  White 778 (49.1)
  Chinese 172 (10.9)
  Hispanic 66 (4.2)
  Japanese 183 (11.6)
Country of origin, n (%)
  United States 1225 (77.3)
  Other 311 (19.6)
  Unknown 49 (3.1)
Household income at V2, n (%)
  <$20,000 142 (9.0)
  $20,000 to <$35,000 183 (11.5)
  $35,000 to <$50,000 236 (14.9)
  $50,000 to <$75,000 389 (24.5)
  ≥$75,000 559 (35.3)
  Unknown 76 (4.8)
Language use at V2, n (%)
  Non-English language only 78 (4.9)
  English and non-English language 181 (11.4)
  English language only 1299 (81.9)
  Unknown 27 (1.8)
Educational attainment, n (%)
  Less than high school 69 (4.4)
  Completed high school or GED 252 (15.9)
  Some college 468 (29.5)
  College graduate 359 (22.6)
  Post-graduate education 425 (26.8)
  Unknown 12 (0.8)
Covered by health insurance at V2, n (%)
  Yes 1489 (93.9)
  No 96 (6.1)
Taking MVI or vitamin D at V2, n (%) 643 (40.8)
Vitamin use over observation period, n (%)
  Neither V2 nor V12 395 (24.9)
  Discontinued after V2 124 (7.8)
  Initiated after V2 539 (34.0)
  Both V2 and V12 519 (32.8)
  Unknown 8 (0.5)
25(OH)D at V2 (nmol/L), mean (SD) 53.8 (24.3)
25(OH)D <50 nmol/L at V2, n (%) 683 (43.1)
25(OH)D ≤30 nmol/L at V2, n (%) 324 (20.4)

V2, Visit 2, GED, general education diploma; MVI, multivitamin; 25(OH)D, 25-hydroxyvitamin D.